UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study

Annals of internal medicine, 2023-03, Vol.176 (3), p.303-310

2023

Volltextzugriff (PDF)

Optimal design of infusion tests for the identification of physiological models of acquired von Willebrand syndrome

Chemical engineering science, 2024-03, Vol.286, p.119660, Article 119660

2024

Volltextzugriff (PDF)

Congenital deficiencies and abnormalities of prothrombin

Blood coagulation & fibrinolysis, 1998-10, Vol.9 (7), p.557-570

1998

Volltextzugriff (PDF)

Identifying Carriers of Type 2N von Willebrand Disease: Procedures and Significance

Clinical and applied thrombosis/hemostasis, 2007-04, Vol.13 (2), p.194-200

2007

Volltextzugriff (PDF)

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

British journal of haematology, 2001-03, Vol.112 (3), p.578-583

2001

Volltextzugriff (PDF)

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Haematologica (Roma), 2010-08, Vol.95 (8), p.1366-1372

2010

Volltextzugriff (PDF)

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA

Journal of clinical pathology, 1994-07, Vol.47 (7), p.625-630

1994

Volltextzugriff (PDF)

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

British journal of haematology, 2002-03, Vol.116 (4), p.899-904

2002

Volltextzugriff (PDF)

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

Haematologica (Roma), 2011-06, Vol.96 (6), p.881-887

2011

Volltextzugriff (PDF)

Which assay is the most suitable to investigate von Willebrand factor functional activity?

Thrombosis and haemostasis, 1999-06, Vol.81 (6), p.994-995

1999

Volltextzugriff (PDF)

Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates

Blood coagulation & fibrinolysis, 1999-04, Vol.10 (3), p.117-120

1999

Volltextzugriff (PDF)

On the release of von Willebrand factor from endothelial cells after venous occlusion

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1216-1217

1998

Volltextzugriff (PDF)

Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases

Case reports in internal medicine, 2014-05, Vol.1 (2)

2014

Volltextzugriff (PDF)

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

Blood, 2003-01, Vol.101 (1), p.151-156

2003

Volltextzugriff (PDF)

ON THE DISCREPANT POST‐DDAVP INCREASE OF FVIII:C AND VON WILLEBRAND FACTOR IN SOME PATIENTS WITH SEVERE VON WILLEBRAND'S DISEASE

British journal of haematology, 1995-10, Vol.91 (2), p.512-513

1995

Volltextzugriff (PDF)

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor

Haematologica (Roma), 2003-06, Vol.88 (6), p.688

2003

Volltextzugriff (PDF)

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease

Blood coagulation & fibrinolysis, 1994-12, Vol.5 (6), p.959-964

1994

Volltextzugriff (PDF)

DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor

Blood coagulation & fibrinolysis, 1996-07, Vol.7 (5), p.549-553

1996

Volltextzugriff (PDF)

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants : effects of DDAVP infusion and protease inhibitors

Annals of hematology, 1995-10, Vol.71 (4), p.189-194

1995

Volltextzugriff (PDF)

Demonstration that venous occlusion fails to release von Willebrand factor multimers

Blood coagulation & fibrinolysis, 1995-09, Vol.6 (6), p.574-578

1995

Volltextzugriff (PDF)

First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects

Blood coagulation & fibrinolysis, 1993-02, Vol.4 (1), p.177-181

1993

Volltextzugriff (PDF)

Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease

Blood coagulation & fibrinolysis, 1991-02, Vol.2 (1), p.33

1991

Volltextzugriff (PDF)

Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy

Acta haematologica, 1994-01, Vol.91 (2), p.73-76

1994

Volltextzugriff (PDF)

TYPE I PADUA: A NEW VARIANT OF VON WILLEBRAND'S DISEASE

British journal of haematology, 1992-08, Vol.81 (4), p.615-616

1992

Volltextzugriff (PDF)

Congenital deficiencies and abnormalities of prothrombin

Blood coagulation & fibrinolysis, 1998-10, Vol.9 (7), p.557

1998

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(83)
Berichte
(2)

Sprache

Englisch
(84)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Science & Technology
(51)
Life Sciences & Biomedicine
(47)
Female
(37)
Hematology
(33)
Male
(30)
Adult
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Von Willebrand Factor
(17)
Von Willebrand Factor - Metabolism
(16)
Hematologic And Hematopoietic Diseases
(15)
Middle Aged
(15)
Platelet Diseases And Coagulopathies
(14)
Adolescent
(11)
Von Willebrand Factor - Chemistry
(11)
Von Willebrand Factor - Genetics
(11)
General & Internal Medicine
(10)
Medicine, General & Internal
(10)
Aged
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study

Optimal design of infusion tests for the identification of physiological models of acquired von Willebrand syndrome

Congenital deficiencies and abnormalities of prothrombin

Identifying Carriers of Type 2N von Willebrand Disease: Procedures and Significance

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

Which assay is the most suitable to investigate von Willebrand factor functional activity?

Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates

On the release of von Willebrand factor from endothelial cells after venous occlusion

Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant

ON THE DISCREPANT POST‐DDAVP INCREASE OF FVIII:C AND VON WILLEBRAND FACTOR IN SOME PATIENTS WITH SEVERE VON WILLEBRAND'S DISEASE

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease

DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants : effects of DDAVP infusion and protease inhibitors

Demonstration that venous occlusion fails to release von Willebrand factor multimers

First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects

Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease

Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy

TYPE I PADUA: A NEW VARIANT OF VON WILLEBRAND'S DISEASE

Congenital deficiencies and abnormalities of prothrombin

Suchergebnisse filtern